高级检索
当前位置: 首页 > 详情页

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究单位: [1]GeneScience Pharmaceuticals Co.,Ltd. [2]Beijing Children's Hospital [3]Tianjin Medical University General Hospital [4]Peking University Third Hospital [5]China-Japan Friendship Hospital [6]Dalian Children's Hospital [7]Xian Children's Hospital [8]Wuhan Children's Hospital [9]Fuzhou Children s Hospital [10]Anhui Provincial Children's Hospital [11]Hunan Children's Hospital [12]Shenzhen Children's Hospital [13]Children's Hospital of Hebei Province [14]Second Affiliated Hospital of Xi'an Jiaotong University [15]Zhengzhou Children's Hospital,China [16]Children's Hospital Of Soochow University [17]Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region [18]The First Affiliated Hospital of Kunming Medical College

研究目的:
To Evaluate the safety and efficacy of PEG Somatropin in the treatment of children with growth hormone deficiency, as well as to study the dosage of PEG Somatropin.

资源点击量:53625 今日访问量:0 总访问量:1665 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)